Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.

Japan Clinical Oncology Group, Toita T, Ohno T, Kaneyasu Y, Uno T, Yoshimura R, Kodaira T, Furutani K, Kasuya G, Ishikura S, Kamura T, Hiraoka M.

Jpn J Clin Oncol. 2010 May;40(5):456-63. doi: 10.1093/jjco/hyp191. Epub 2010 Feb 4.

PMID:
20133334
2.

Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning.

Marnitz S, Köhler C, Schneider A, Seiler F, Hinkelbein W.

Strahlenther Onkol. 2006 Feb;182(2):80-5.

PMID:
16447014
3.

Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies.

Chao KS, Lin M.

Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1147-52.

PMID:
12419442
4.

A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer.

Toita T, Ohno T, Kaneyasu Y, Kato T, Uno T, Hatano K, Norihisa Y, Kasamatsu T, Kodaira T, Yoshimura R, Ishikura S, Hiraoka M; JCOG Radiation Therapy Study Group.

Jpn J Clin Oncol. 2011 Sep;41(9):1119-26. doi: 10.1093/jjco/hyr096.

PMID:
21875938
5.

Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.

Kasuya G, Toita T, Furutani K, Kodaira T, Ohno T, Kaneyasu Y, Yoshimura R, Uno T, Yogi A, Ishikura S, Hiraoka M.

Radiat Oncol. 2013 Jun 8;8:139. doi: 10.1186/1748-717X-8-139.

6.

Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.

Taylor A, Rockall AG, Reznek RH, Powell ME.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1604-12. Epub 2005 Sep 29.

PMID:
16198509
7.

IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.

Ahmed RS, Kim RY, Duan J, Meleth S, De Los Santos JF, Fiveash JB.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):505-12.

PMID:
15380585
8.

Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.

Shih HA, Harisinghani M, Zietman AL, Wolfgang JA, Saksena M, Weissleder R.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1262-9.

PMID:
16253781
9.

PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study.

Mutic S, Malyapa RS, Grigsby PW, Dehdashti F, Miller TR, Zoberi I, Bosch WR, Esthappan J, Low DA.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):28-35.

PMID:
12504033
10.

An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition.

Taylor A, Rockall AG, Powell ME.

Clin Oncol (R Coll Radiol). 2007 Sep;19(7):542-50. Epub 2007 Jul 10.

PMID:
17624745
11.

Clinical and anatomical guidelines in pelvic cancer contouring for radiotherapy treatment planning.

Portaluri M, Bambace S, Perez C, Giuliano G, Angone G, Scialpi M, Pili G, Didonna V, Alloro E.

Cancer Radiother. 2004 Aug;8(4):222-9.

PMID:
15450515
12.
13.

Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?

Adli M, Mayr NA, Kaiser HS, Skwarchuk MW, Meeks SL, Mardirossian G, Paulino AC, Montebello JF, Gaston RC, Sorosky JI, Buatti JM.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):230-8.

PMID:
12909238
14.

Where to look for the sentinel lymph node in cervical cancer.

Bader AA, Winter R, Haas J, Tamussino KF.

Am J Obstet Gynecol. 2007 Dec;197(6):678.e1-7.

PMID:
18060980
15.

Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.

Ganswindt U, Paulsen F, Corvin S, Hundt I, Alber M, Frey B, Stenzl A, Bares R, Bamberg M, Belka C.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):347-55.

PMID:
17236960
16.

Magnetic resonance imaging in the treatment planning of radiation therapy in carcinoma of the cervix treated with the four-field pelvic technique.

Thomas L, Chacon B, Kind M, Lasbareilles O, Muyldermans P, Chemin A, Le Treut A, Pigneux J, Kantor G.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):827-32.

PMID:
9128958
17.

Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.

Lee JM, Lee KB, Lee SK, Park CY.

J Obstet Gynaecol Res. 2007 Jun;33(3):288-93.

PMID:
17578357
18.

Vessel-contouring-based pelvic radiotherapy in patients with uterine cervical cancer.

Uno T, Isobe K, Ueno N, Kobayashi H, Sanayama Y, Mitsuhashi A, Shozu M, Ito H.

Jpn J Clin Oncol. 2009 Jun;39(6):376-80. doi: 10.1093/jjco/hyp029. Epub 2009 Apr 7.

PMID:
19351660
19.

Position shifts and volume changes of pelvic and para-aortic nodes during IMRT for patients with cervical cancer.

Schippers MG, Bol GH, de Leeuw AA, van der Heide UA, Raaymakers BW, Verkooijen HM, Jürgenliemk-Schulz IM.

Radiother Oncol. 2014 Jun;111(3):442-5. doi: 10.1016/j.radonc.2014.05.013. Epub 2014 Jul 14.

PMID:
25034933
20.

[Risk factors and prognosis of node-positive cervical carcinoma].

Feng SY, Zhang YN, Liu JG.

Ai Zheng. 2005 Oct;24(10):1261-6. Chinese.

PMID:
16219145

Supplemental Content

Support Center